van Els CACM - Search Results

1

A synthetic human 3D in vitro lymphoid model enhancing B-cell survival and functional differentiation.

Braham MVJ, van Binnendijk RS, Buisman AM, Mebius RE, de Wit J, van Els CACM. Braham MVJ, et al. Among authors: van binnendijk rs, van els cacm. iScience. 2022 Dec 5;26(1):105741. doi: 10.1016/j.isci.2022.105741. eCollection 2023 Jan 20. iScience. 2022. PMID: 36590159 Free PMC article.

2

Minimal phenotype panels. A method for achieving maximum population coverage with a minimum of HLA antigens.

Schipper RF, van Els CA, D'Amaro J, Oudshoorn M. Schipper RF, et al. Hum Immunol. 1996 Dec;51(2):95-8. doi: 10.1016/s0198-8859(96)00138-3. Hum Immunol. 1996. PMID: 8960911

3

Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin.

Stenger RM, Poelen MC, Moret EE, Kuipers B, Bruijns SC, Hoogerhout P, Hijnen M, King AJ, Mooi FR, Boog CJ, van Els CA. Stenger RM, et al. Infect Immun. 2009 Feb;77(2):896-903. doi: 10.1128/IAI.00769-08. Epub 2008 Nov 17. Infect Immun. 2009. PMID: 19015250 Free PMC article.

4

Identifying the epitope-specific T cell response to virus infections.

Soethout EC, Meiring HD, de Jong AP, van Els CA. Soethout EC, et al. Vaccine. 2007 Apr 20;25(16):3200-3. doi: 10.1016/j.vaccine.2007.01.029. Epub 2007 Jan 17. Vaccine. 2007. PMID: 17276553 Review.

5

Quality-control issues and approaches in vaccine development.

Metz B, van den Dobbelsteen G, van Els C, van der Gun J, Levels L, van der Pol L, Rots N, Kersten G. Metz B, et al. Expert Rev Vaccines. 2009 Feb;8(2):227-38. doi: 10.1586/14760584.8.2.227. Expert Rev Vaccines. 2009. PMID: 19196202 Free article. Review.

6

Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells.

Heeney JL, van Els C, de Vries P, ten Haaft P, Otting N, Koornstra W, Boes J, Dubbes R, Niphuis H, Dings M, Cranage M, Norley S, Jonker M, Bontrop RE, Osterhaus A. Heeney JL, et al. J Exp Med. 1994 Aug 1;180(2):769-74. doi: 10.1084/jem.180.2.769. J Exp Med. 1994. PMID: 8046353 Free PMC article.

7

Susceptibility of human male keratinocytes to MHC-restricted H-Y-specific lysis.

van Els CA, de Bueger MM, Kempenaar J, Ponec M, Goulmy E. van Els CA, et al. J Exp Med. 1989 Oct 1;170(4):1469-74. doi: 10.1084/jem.170.4.1469. J Exp Med. 1989. PMID: 2794866 Free PMC article.

8

Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. I. Absence of correlation with cytotoxic effector cells.

van Els CA, Bakker A, Zwinderman AH, Zwaan FE, van Rood JJ, Goulmy E. van Els CA, et al. Transplantation. 1990 Jul;50(1):62-6. doi: 10.1097/00007890-199007000-00011. Transplantation. 1990. PMID: 2368152

9

Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. II. Evidence of a possible involvement of proliferative T cells.

van Els CA, Bakker A, Zwinderman AH, Zwaan FE, van Rood JJ, Goulmy E. van Els CA, et al. Transplantation. 1990 Jul;50(1):67-71. doi: 10.1097/00007890-199007000-00012. Transplantation. 1990. PMID: 2142346

10

Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1.

van Baalen CA, Klein MR, Huisman RC, Dings ME, Kerkhof Garde SR, Geretti AM, Gruters R, van Els CA, Miedema F, Osterhaus AD. van Baalen CA, et al. J Gen Virol. 1996 Aug;77 ( Pt 8):1659-65. doi: 10.1099/0022-1317-77-8-1659. J Gen Virol. 1996. PMID: 8760412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters